Vivo Capital, LLC Q4 2023 Filing
Filed February 7, 2024
Portfolio Value
$1.2T
Holdings
47
Report Date
Q4 2023
Filing Type
13F-HR
All Holdings (47 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SLNOSoleno Therapeutics Inc | 8,418,093 | $338.8B | 27.74% | |
| 2 | GRCLGracell Biotechnologies Inc | 9,546,485 | $95.8B | 7.85% | |
| 3 | VRNAVerona Pharma PLC | 4,249,918 | $84.5B | 6.92% | |
| 4 | HRMYHarmony Biosciences Holdings Inc | 2,606,247 | $84.2B | 6.89% | |
| 5 | ALXOALX Oncology Holdings Inc | 4,220,048 | $62.8B | 5.14% | |
| 6 | AVDLAvadel Pharmaceuticals PLC | 4,096,428 | $57.8B | 4.74% | |
| 7 | GONGeron Corp | 24,143,681 | $50.9B | 4.17% | |
| 8 | TERNTerns Pharmaceuticals Inc | 6,657,992 | $43.2B | 3.54% | |
| 9 | VRDNViridian Therapeutics Inc | 1,678,207 | $36.6B | 2.99% | |
| 10 | TARSTarsus Pharmaceuticals Inc | 1,784,006 | $36.1B | 2.96% | |
| 11 | —Icosavax, Inc. | 1,704,568 | $26.9B | 2.20% | |
| 12 | OLMAOlema Pharmaceuticals Inc | 1,873,704 | $26.3B | 2.15% | |
| 13 | CATBUSDAstria Therapeutics Inc | 2,482,727 | $19.1B | 1.56% | |
| 14 | NVLSEURAlpine Immune Sciences Inc | 819,275 | $15.6B | 1.28% | |
| 15 | TRMLTourmaline Bio Inc. | 591,882 | $15.5B | 1.27% | |
| 16 | CMPSCompass Pathway PLC | 1,608,000 | $14.1B | 1.15% | |
| 17 | DYNDyne Therapeutics Inc | 1,035,136 | $13.8B | 1.13% | |
| 18 | COGTCogent Biosciences Inc | 2,244,941 | $13.2B | 1.08% | |
| 19 | VSTMVerastem Inc | 1,538,461 | $12.5B | 1.03% | |
| 20 | CRNXCrinetics Pharmaceuticals Inc | 350,000 | $12.5B | 1.02% | |
| 21 | IOBTIO Biotech Inc | 6,173,439 | $11.6B | 0.95% | |
| 22 | ZLABZai Lab Ltd | 411,677 | $11.3B | 0.92% | |
| 23 | APGEApogee Therapeutics Inc | 400,000 | $11.2B | 0.92% | |
| 24 | KALVKalVista Pharmaceuticals Inc. | 856,008 | $10.5B | 0.86% | |
| 25 | —Genetron Holdings Ltd | 2,708,056 | $10.0B | 0.82% | |
| 26 | SERASera Prognostics Inc | 1,650,440 | $9.9B | 0.81% | |
| 27 | YB4PSavara Inc | 2,088,323 | $9.8B | 0.80% | |
| 28 | SLNSilence Therapeutics PLC | 510,204 | $8.9B | 0.73% | |
| 29 | ALLKGUSDAllakos Inc | 2,988,000 | $8.2B | 0.67% | |
| 30 | PHVSPharvaris NV | 285,000 | $8.0B | 0.65% | |
| 31 | ORICOric Pharmaceuticals Inc | 849,681 | $7.8B | 0.64% | |
| 32 | —Rayzebio Inc | 110,581 | $6.9B | 0.56% | |
| 33 | ENGNEngene Holdings Inc. | 678,705 | $6.3B | 0.51% | |
| 34 | CMPXCompass Therapeutics Inc | 3,556,023 | $5.5B | 0.45% | |
| 35 | IOVAIovance Biotherapeutics Inc | 655,057 | $5.3B | 0.44% | |
| 36 | TILInstil Bio Inc | 624,340 | $4.8B | 0.39% | |
| 37 | ARWRArrowhead Pharmaceuticals Inc | 137,411 | $4.2B | 0.34% | |
| 38 | BOLT1EURBolt Therapeutics Inc | 3,521,291 | $3.9B | 0.32% | |
| 39 | DCTHDelcath Systems, Inc. | 855,191 | $3.6B | 0.29% | |
| 40 | RZLTRezolute Inc | 3,242,842 | $3.2B | 0.26% | |
| 41 | UNCYUnicycive Therapeutics | 3,470,152 | $3.0B | 0.25% | |
| 42 | —DBV Technologies SA | 2,708,875 | $2.6B | 0.21% | |
| 43 | ALGSAligos Therapeutics Inc | 3,547,030 | $2.4B | 0.19% | |
| 44 | CDXSCodexis, Inc | 388,144 | $1.2B | 0.10% | |
| 45 | WHWKAadi Bioscience Inc | 509,572 | $1.0B | 0.08% | |
| 46 | FIXXEURHomology Medicines, Inc. | 370,068 | $225.0M | 0.02% | |
| 47 | DTILPrecision Biosciences Inc | 140,255 | $51.2M | 0.00% |